Skip to content

The Effect of an Integrated Mobile Health Platform on Early Detection of Clinical Outcomes of Critical Ill Patients

The Effect of an Integrated Mobile Health Platform on Early Detection of Clinical Outcomes of Critical Ill Patients

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07773675
Enrollment
250
Registered
2026-08-19
Start date
2026-07-28
Completion date
2027-05-28
Last updated
2026-08-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Clinical Outcomes, Mobile Health Platform

Keywords

Mobile health platform, Early detection

Brief summary

This study will aim to examine the Effect of integrated Mobile Health Platform on early detection of clinical outcomes of Critical ill patients.

Detailed description

This study clarify if using if using the electric platform will reduce the complications in critical ill patients this complications include respiratory complications, renal complications, cardiac complications

Interventions

DEVICEIntegrated Mobile Health Platform

A digital health platform integrated with ICU monitoring systems to automatically collect, record, and analyze patient vital signs and lab trends, generating real-time early warning alerts for healthcare providers.

Sponsors

Sohag University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Masking description

This is an open-label study where patients, care providers, and investigators cannot be masked due to the nature of the digital health intervention. However, the biostatistician/data analyst will be blinded to the treatment assignment during data analysis to minimize detection and reporting bias.

Intervention model description

This study utilizes a prospective, quasi-experimental, non-randomized controlled interventional design to evaluate the efficacy of an integrated Mobile Health (mHealth) platform.

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Adult patients aged 18-65 years. 2. Anticipated ICU stay of more than 24 hours. 3. Clinical requirement and ability to continuously monitor vital signs and urine output. 4. Obtained written informed consent from the patient or their legal guardians.

Exclusion criteria

1. Patients placed in strict isolation due to highly infectious diseases. 2. Death within 24 hours of ICU admission. 3. Patients transferred from another external Intensive Care Unit. 4. Re-admission to the ICU during the active study period. 5. Pre-existing chronic altered consciousness or irreversible neurological deficit. 6. Patients who underwent pre-hospital cardiopulmonary resuscitation (CPR).

Design outcomes

Primary

MeasureTime frameDescription
ICU Mortality RateFrom ICU admission up to 30 days.The percentage of critically ill patients who die in the General Intensive Care Unit during their hospital stay. This will evaluate the impact of the mHealth platform on reducing patient mortality.

Secondary

MeasureTime frameDescription
ICU Length of Stay (LOS)From ICU admission up to 30 days.The total number of days each patient spends in the General Intensive Care Unit from the day of admission until discharge.
Incidence of Clinical ComplicationsDaily from study enrollment until ICU discharge, up to 30 days.The occurrence of organ-specific complications during the ICU stay, including respiratory (pulmonary edema, ARDS, pneumonia, difficult weaning), cardiac (cardiac arrest, shock, arrhythmia), and renal complications (acute renal failure).

Countries

Egypt

Contacts

CONTACTAsmaa Yassen, MSc
asmaayaseen487@gmail.com+201095196756
CONTACTMogedda Mehany, PhD
+201066645420

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 20, 2026